These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Epigenetic vulnerabilities of leukemia harboring inactivating EZH2 mutations. Alqazzaz MA; Luciani GM; Vu V; Machado RAC; Szewczyk MM; Adamson EC; Cheon S; Li F; Arrowsmith CH; Minden MD; Barsyte-Lovejoy D Exp Hematol; 2024 Feb; 130():104135. PubMed ID: 38072134 [TBL] [Abstract][Full Text] [Related]
43. Epigenetic regulation of embryonic ectoderm development in stem cell differentiation and transformation during ontogenesis. Huang L; Li F; Ye L; Yu F; Wang C Cell Prolif; 2023 Apr; 56(4):e13413. PubMed ID: 36727213 [TBL] [Abstract][Full Text] [Related]
44. Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review. Gautam N; Kaur M; Kaur S J Cancer Res Ther; 2021; 17(2):311-326. PubMed ID: 33063698 [TBL] [Abstract][Full Text] [Related]
45. Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancer. Chu L; Qu Y; An Y; Hou L; Li J; Li W; Fan G; Song BL; Li E; Zhang L; Qi W Cell Death Dis; 2022 Feb; 13(2):155. PubMed ID: 35169119 [TBL] [Abstract][Full Text] [Related]
46. Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader. Yu X; Wang J; Gong W; Ma A; Shen Y; Zhang C; Liu X; Cai L; Liu J; Wang GG; Jin J Oncogene; 2023 Mar; 42(13):994-1009. PubMed ID: 36747009 [TBL] [Abstract][Full Text] [Related]
47. Ezh1 and Ezh2 differentially regulate PSD-95 gene transcription in developing hippocampal neurons. Henriquez B; Bustos FJ; Aguilar R; Becerra A; Simon F; Montecino M; van Zundert B Mol Cell Neurosci; 2013 Nov; 57():130-43. PubMed ID: 23932971 [TBL] [Abstract][Full Text] [Related]
48. AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition. Zhang KL; Shen QQ; Fang YF; Sun YM; Ding J; Chen Y Acta Pharmacol Sin; 2019 Dec; 40(12):1587-1595. PubMed ID: 31171828 [TBL] [Abstract][Full Text] [Related]
49. The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex. He Y; Selvaraju S; Curtin ML; Jakob CG; Zhu H; Comess KM; Shaw B; The J; Lima-Fernandes E; Szewczyk MM; Cheng D; Klinge KL; Li HQ; Pliushchev M; Algire MA; Maag D; Guo J; Dietrich J; Panchal SC; Petros AM; Sweis RF; Torrent M; Bigelow LJ; Senisterra G; Li F; Kennedy S; Wu Q; Osterling DJ; Lindley DJ; Gao W; Galasinski S; Barsyte-Lovejoy D; Vedadi M; Buchanan FG; Arrowsmith CH; Chiang GG; Sun C; Pappano WN Nat Chem Biol; 2017 Apr; 13(4):389-395. PubMed ID: 28135237 [TBL] [Abstract][Full Text] [Related]
50. Live-cell imaging reveals the dynamics of PRC2 and recruitment to chromatin by SUZ12-associated subunits. Youmans DT; Schmidt JC; Cech TR Genes Dev; 2018 Jun; 32(11-12):794-805. PubMed ID: 29891558 [TBL] [Abstract][Full Text] [Related]
51. Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation. Pyziak K; Sroka-Porada A; Rzymski T; Dulak J; Łoboda A Drug Dev Res; 2021 Sep; 82(6):730-753. PubMed ID: 33565092 [TBL] [Abstract][Full Text] [Related]
52. PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs. Shan Y; Liang Z; Xing Q; Zhang T; Wang B; Tian S; Huang W; Zhang Y; Yao J; Zhu Y; Huang K; Liu Y; Wang X; Chen Q; Zhang J; Shang B; Li S; Shi X; Liao B; Zhang C; Lai K; Zhong X; Shu X; Wang J; Yao H; Chen J; Pei D; Pan G Nat Commun; 2017 Sep; 8(1):672. PubMed ID: 28939884 [TBL] [Abstract][Full Text] [Related]